Literature DB >> 22960192

Excretion and toxicity of gold-iron nanoparticles.

James T Jenkins1, David L Halaney, Konstantin V Sokolov, Li L Ma, Heather J Shipley, Smridhi Mahajan, Christopher L Louden, Reto Asmis, Thomas E Milner, Keith P Johnston, Marc D Feldman.   

Abstract

Though gold nanoparticles have been considered bio-inert, recent studies have questioned their safety. To reduce the potential for toxicity, we developed a nanoclustering of gold and iron oxide as a nanoparticle (nanorose) which biodegrades into subunits to facilitate rapid excretion. In this present study, we demonstrate acid and macrophage lysosomal degradation of nanorose via loss of the near-infrared optical shift, and clearance of the nanorose in vivo following i.v. administration in C57BL/6 mice by showing gold concentration is significantly reduced in 11 murine tissues in as little as 31 days (P < 0.01). Hematology and chemistry show no toxicity of nanorose injected mice up to 14 days after administration. We conclude that the clustering design of nanorose does enhance the excretion of these nanoparticles, and that this could be a viable strategy to limit the potential toxicity of gold nanoparticles for clinical applications. FROM THE CLINICAL EDITOR: The potential toxicity of nanomaterials is a critically important limiting factor in their more widespread clinical application. Gold nanoparticles have been classically considered bio-inert, but recent studies have questioned their safety. The authors of this study have developed a clustering gold and iron oxide nanoparticle (nanorose), which biodegrades into subunits to facilitate rapid excretion, resulting in reduced toxicity. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960192     DOI: 10.1016/j.nano.2012.08.007

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  7 in total

Review 1.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

Review 2.  The Combination of Laser Therapy and Metal Nanoparticles in Cancer Treatment Originated From Epithelial Tissues: A Literature Review.

Authors:  Reza Fekrazad; Nafiseh Naghdi; Hanieh Nokhbatolfoghahaei; Hossein Bagheri
Journal:  J Lasers Med Sci       Date:  2016-03-27

3.  Fate of Antibody-Targeted Ultrasmall Gold Nanoparticles in Cancer Cells after Receptor-Mediated Uptake.

Authors:  Sangheon Han; Tomasz Zal; Konstantin V Sokolov
Journal:  ACS Nano       Date:  2021-05-20       Impact factor: 15.881

4.  Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy.

Authors:  Jun-Ying Wang; Jie Chen; Jiang Yang; Hao Wang; Xiu Shen; Yuan-Ming Sun; Meili Guo; Xiao-Dong Zhang
Journal:  Int J Nanomedicine       Date:  2016-07-27

5.  Towards optimized naphthalocyanines as sonochromes for photoacoustic imaging in vivo.

Authors:  Mitchell J Duffy; Oriol Planas; Andreas Faust; Thomas Vogl; Sven Hermann; Michael Schäfers; Santi Nonell; Cristian A Strassert
Journal:  Photoacoustics       Date:  2018-01-11

6.  Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement.

Authors:  Ioana Mihaela Popescu Din; Mihaela Balas; Anca Hermenean; Luce Vander Elst; Sophie Laurent; Carmen Burtea; Ludmila Otilia Cinteza; Anca Dinischiotu
Journal:  Materials (Basel)       Date:  2020-06-15       Impact factor: 3.623

7.  4D Multimodal Nanomedicines Made of Nonequilibrium Au-Fe Alloy Nanoparticles.

Authors:  Veronica Torresan; Daniel Forrer; Andrea Guadagnini; Denis Badocco; Paolo Pastore; Maurizio Casarin; Annabella Selloni; Diego Coral; Marcelo Ceolin; Marcela B Fernández van Raap; Alice Busato; Pasquina Marzola; Antonello E Spinelli; Vincenzo Amendola
Journal:  ACS Nano       Date:  2020-09-15       Impact factor: 15.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.